ArticleFrontiers in oncology2020

PROTAC Bromodomain Inhibitor ARV-825 Displays Anti-Tumor Activity in Neuroblastoma by Repressing Expression of

Zhiheng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.